Vanessa Rivera-Amill to Antibodies, Viral
This is a "connection" page, showing publications Vanessa Rivera-Amill has written about Antibodies, Viral.
Connection Strength
0.447
-
Munoz-Jordan J, Cardona J, Beltr?n M, Col?n C, Schiffer J, Stewart-Clark E, Zellner B, Semenova V, Li Y, Jia LT, Maniatis P, Pawloski L, Adams L, Paz-Bailey G, Rivera-Amill V, Medina F. Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):375-377.
Score: 0.177
-
Medina FA, Vila F, Premkumar L, Lorenzi O, Paz-Bailey G, Alvarado LI, Rivera-Amill V, de Silva A, Waterman S, Mu?oz-Jord?n J. Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission. Am J Trop Med Hyg. 2021 12 20; 106(2):585-592.
Score: 0.174
-
Adams LE, Hitchings MDT, Medina FA, Rodriguez DM, S?nchez-Gonz?lez L, Moore H, Whitehead SS, Mu?oz-Jord?n JL, Rivera-Amill V, Paz-Bailey G. Previous Dengue Infection among Children in Puerto Rico and Implications for Dengue Vaccine Implementation. Am J Trop Med Hyg. 2023 08 02; 109(2):413-419.
Score: 0.048
-
Powers JM, Lyski ZL, Weber WC, Denton M, Streblow MM, Mayo AT, Haese NN, Nix CD, Rodr?guez-Santiago R, Alvarado LI, Rivera-Amill V, Messer WB, Streblow DN. Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoprotein. PLoS Negl Trop Dis. 2023 03; 17(3):e0011154.
Score: 0.047